全文获取类型
收费全文 | 80814篇 |
免费 | 6345篇 |
国内免费 | 258篇 |
专业分类
耳鼻咽喉 | 911篇 |
儿科学 | 2085篇 |
妇产科学 | 1139篇 |
基础医学 | 10951篇 |
口腔科学 | 859篇 |
临床医学 | 8631篇 |
内科学 | 17230篇 |
皮肤病学 | 910篇 |
神经病学 | 8202篇 |
特种医学 | 3145篇 |
外科学 | 13025篇 |
综合类 | 928篇 |
一般理论 | 92篇 |
预防医学 | 6046篇 |
眼科学 | 1969篇 |
药学 | 5539篇 |
中国医学 | 94篇 |
肿瘤学 | 5661篇 |
出版年
2023年 | 610篇 |
2022年 | 870篇 |
2021年 | 2429篇 |
2020年 | 1367篇 |
2019年 | 2218篇 |
2018年 | 2552篇 |
2017年 | 1814篇 |
2016年 | 1910篇 |
2015年 | 2230篇 |
2014年 | 3234篇 |
2013年 | 4107篇 |
2012年 | 6559篇 |
2011年 | 6824篇 |
2010年 | 3722篇 |
2009年 | 3272篇 |
2008年 | 5467篇 |
2007年 | 5654篇 |
2006年 | 5264篇 |
2005年 | 5206篇 |
2004年 | 4709篇 |
2003年 | 4325篇 |
2002年 | 3906篇 |
2001年 | 673篇 |
2000年 | 482篇 |
1999年 | 625篇 |
1998年 | 809篇 |
1997年 | 611篇 |
1996年 | 505篇 |
1995年 | 452篇 |
1994年 | 432篇 |
1993年 | 425篇 |
1992年 | 321篇 |
1991年 | 262篇 |
1990年 | 219篇 |
1989年 | 226篇 |
1988年 | 196篇 |
1987年 | 178篇 |
1986年 | 164篇 |
1985年 | 180篇 |
1984年 | 205篇 |
1983年 | 171篇 |
1982年 | 252篇 |
1981年 | 264篇 |
1980年 | 182篇 |
1979年 | 131篇 |
1978年 | 145篇 |
1977年 | 116篇 |
1976年 | 84篇 |
1975年 | 69篇 |
1974年 | 68篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
2.
3.
Kara S. Tanaka MD Veronica R. Andaya BA Steven W. Thorpe MD Kenneth R. Gundle MD James B. Hayden MD Yee-Cheen Duong MD Raffi S. Avedian MD David G. Mohler MD Lee J. Morse MD Melissa N. Zimel MD Richard J. O'Donnell MD Andrew Fang MD Robert Lor Randall MD Tina H. Tran BS Christin New BA Rosanna L. Wustrack MD other members of Study Group FORCE 《Journal of surgical oncology》2023,127(1):148-158
4.
Triposkiadis Filippos Xanthopoulos Andrew Skoularigis John Starling Randall C. 《Heart failure reviews》2022,27(6):1991-2003
Heart Failure Reviews - The nitric oxide (NO)–guanylate cyclase (GC)–cyclic guanosine monophosphate (cGMP) pathway plays an important role in cardiovascular, pulmonary and renal... 相似文献
5.
6.
Xin Yi Wong Andrew Qi Jun Lim Qianyu Shen John Whay Kuang Chia Min Hoe Chew Wah Siew Tan 《Current medical research and opinion》2020,36(10):1677-1686
Abstract
Objective
Ras wild-type metastatic colorectal cancers (mCRC) may be treated with anti-vascular endothelial growth factor (VEGF) or anti-epidermal growth factor receptor (EGFR) agents. We aim to estimate patients’ preferences for mCRC treatment and relative importance of cost, efficacy improvement, avoidance of side effects and therapy convenience, and relative uptake between profiles that resemble Bevacizumab (anti-VEGF) and Cetuximab (anti-EGFR), two commonly prescribed mCRC targeted therapies. 相似文献7.
8.
9.
William R. C. Knight Cara R. Baker Nyree Griffin Wahyu Wulaningsih Mark Kelly Andrew R. Davies James A. Gossage 《British journal of cancer》2021,124(10):1653
Background A high Mandard score implies a non-response to chemotherapy in oesophageal adenocarcinoma. However, some patients exhibit tumour volume reduction and a nodal response despite a high score. This study examines survival and recurrence patterns in these patients.Methods Clinicopathological factors were analysed using multivariable Cox regression assessing time to death and recurrence. Computed tomography-estimated tumour volume change was examined in a subgroup of consecutive patients.Results Five hundred and fifty-five patients were included. Median survival was 55 months (Mandard 1–3) and 21 months (Mandard 4 and 5). In the Mandard 4 and 5 group (332 patients), comparison between complete nodal responders and persistent nodal disease showed improved survival (90 vs 18 months), recurrence rates (locoregional 14.75 vs 28.74%, systemic 24.59 vs 48.42%) and circumferential resection margin positivity (22.95 vs 68.11%). Complete nodal response independently predicted improved survival (hazard ratio 0.34 (0.16–0.74). Post-chemotherapy tumour volume reduction was greater in patients with a complete nodal response (−16.3 vs −7.7 cm3, p = 0.033) with no significant difference between Mandard groups.Conclusion Patients with a complete nodal response to chemotherapy have significantly improved outcomes despite a poor Mandard score. High Mandard score does not correspond with a non-response to chemotherapy in all cases and patients with nodal downstaging may still benefit from adjuvant chemotherapy.Subject terms: Oesophageal cancer, Surgical oncology 相似文献
10.
Christian Holm Hansen Shelley Lees Saidi Kapiga Janet Seeley Tony Barnett 《Global public health》2020,15(3):402-413
ABSTRACTMeasuring hope reliably and accurately remains an important research objective, not least in less prosperous settings where ‘holding on to hope’ may be critically important in the struggle against adverse life conditions. The State Hope Scale was designed for use in the US. Despite reported application in diverse cultures and using translations the scale has not been extensively validated outside US populations. This study contributes to a larger project exploring the measurement of hope and provides a critique of Snyder’s scale as used in a Tanzanian female population of 1021 urban microfinance participants. We evaluate the scale’s validity through assessment of the empirical distribution of scores, item response profiles, internal consistency and discriminatory ability. Participants mostly scored very high and many reached very near the maximum attainable score. Hardly any endorsed the negative half of the response scale. Several problems are discussed including poor discrimination and strong evidence of acquiescence response bias. We also found little association of the scale scores with hypothesised correlates of hope. Future improvements on the measurement of hope are recommended, especially in studies outside the narrow Western context in which the scale was devised. 相似文献